about us
As a knowledge-based company, Parand Darou pharmaceutical company started its activity in 2006 with the production of Narcotic APIs. Parand Darou Company is the second company in the private sector that received the license to produce narcotic products from the Food and Drug Organization of Iran. Extracting the Opioid raw materials, manufactured effective medicinal substances such as Codeine Phosphate, Noscapine, Thebaine, Papaverine and Oxycodone, in addition to meet the needs of domestic customers, it has exported its products to the world markets. In 2019, the company established a syrup line and received a GMP certificate and launched the production cycle of narcotic FDF as well. In July 2022, Kimyagaran Group (public stock) purchased the management shares of Parand Darou Pharmaceutical Company and aims to create a turning point in the growth, development and excellence of the company by cooperating with the expert and experienced management team.
Establishment of the Company
Parand Darou Pharmaceutical API Manufacturing Company was established in 2006 and officially registered with the Companies and Non-Commercial Institutes Registration Office of Saveh. Since its foundation, the company has focused on the development and production of high-quality Active Pharmaceutical Ingredients (APIs) to support both domestic and international pharmaceutical markets. With a vision to contribute to the advancement of healthcare, Parand Darou has invested in state-of-the-art facilities, modern laboratories, and a professional workforce composed of skilled experts, pharmacists, and researchers.
Over the years, the company has gained recognition for its commitment to innovation, quality assurance, and compliance with international standards. Its manufacturing processes are designed in accordance with Good Manufacturing Practice (GMP) guidelines, ensuring safety, reliability, and consistency in all products. Parand Darou also emphasizes research and development, continuously working to expand its portfolio of APIs and meet the growing needs of the pharmaceutical industry.
By combining technical expertise, strict quality control, and customer-oriented strategies, Parand Darou Pharmaceutical API Manufacturing Company has become a trusted partner for many pharmaceutical companies. Today, it continues to grow and strengthen its position as a reliable supplier, striving to improve global health and contribute to better patient outcomes through innovative and effective pharmaceutical solutions.
Establishment of Syrup Production Line
The establishment of a syrup production line marked a significant milestone in the development of Parand Darou. With this achievement, the company expanded its scope of activities beyond the manufacturing of Active Pharmaceutical Ingredients (APIs) and entered the field of finished pharmaceutical products. In particular, Parand Darou initiated the production of final narcotic products, a step that required advanced technology, strict regulatory compliance, and highly specialized expertise.
This strategic move not only demonstrated the company’s ability to innovate but also positioned it as a fully integrated pharmaceutical manufacturer. By investing in modern facilities, automated equipment, and rigorous quality control systems, Parand Darou ensured that its syrup production line met international standards of safety, efficacy, and reliability.
The expansion into finished dosage forms allowed the company to respond more directly to the needs of patients and healthcare providers. It also strengthened Parand Darou’s role in the pharmaceutical industry, transforming it from a raw material supplier into a trusted partner capable of delivering comprehensive pharmaceutical solutions.
